A new study in eLife provides evidence that our brains may drain waste via our lymphatic vessels. The vessels may act as a 'pipeline' between the brain and immune system. Researchers say the findings could alter the way we think about how the brain and immune system inter-relate.
12 genes associated with familial multiple sclerosis have been identified. The findings provide a molecular rationale for the chronic inflammation, demyelination and neurodegeneration associated with MS. Identifying new genetic targets could help with the development of novel treatments to prevent multiple sclerosis in those with a genetic risk.
A new study reveals the structure of a crucial ion channel and shed new light on it's possible role in immune functions.
MW-151, a new drug that blocks 'bad' inflammation in the brain is about to be tested in a new human trial. Researchers believe the new drug could help stave off dementia.
Reducing the expression of the protein TOM1 in mouse models of Alzheimer's disease increased the pathology, exacerbated cognitive problems, and raised levels of inflammation in the brain. Restoring TOM1 reversed the effects. Findings suggest a new therapeutic target for treating dementia.
Researchers found an increased inflammatory signal in patients with the C90rf72 subtype of ALS. The increased inflammatory biomarkers could be found in peripheral serum tests.
According to researchers, older adults who exercised for most of their lives showed signs of slowed down aging. The study reports those who actively cycled into older age had lower cholesterol levels and better immune systems than those who did not partake in regular exercise.
According to a new study, an insufficient amount of good bacteria could have a direct link to MS.